Skip to main content
. 2021 Nov 19;184(26):6229–6242.e18. doi: 10.1016/j.cell.2021.11.026
Parameter Definition Default value
N Population size 108
R0 Reproduction number (WT) 2.5
γ Recovery rate 1/14 days-1
β Transmission rate R0γN
φ Cross-reactivity between WT and variant 1 or 0.6
ω Maximum vaccine efficacy 0.95
α1 Antigenic mismatch between vaccine and WT 0
α2 Antigenic mismatch between vaccine and variant 1φ
κI Eligibility of infected individuals for vaccination; 1 = eligible, 0 = ineligible 1
κR Eligibility of recovered individuals for vaccination; 1 = eligible, 0 = ineligible 1
λ Increase in transmissibility of variant relative to WT 0 or 0.6
τ2 Time of variant introduction 9 months
τvax Start of vaccine rollout Varies
v Daily per-capita vaccination rate Varies
c Final vaccination coverage 100%
r Reduction in transmission due to nonpharmaceutical interventions 0.4